- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
c-RET antibody recognizes RET proto-oncogene, a receptor tyrosine kinase encoded by the RET gene located on chromosome 10q11.21. RET is a transmembrane receptor that functions as a critical mediator of glial cell line-derived neurotrophic factor signaling. Upon ligand binding through GFR alpha co-receptors, RET undergoes dimerization and autophosphorylation, activating downstream pathways including MAPK, PI3K-AKT, and JAK-STAT signaling cascades. These pathways regulate cellular proliferation, survival, differentiation, and migration.
RET proto-oncogene is widely studied in oncology due to its role in tumorigenesis. Activating mutations, gene rearrangements, and overexpression of RET have been identified in medullary thyroid carcinoma, papillary thyroid carcinoma, lung adenocarcinoma, and multiple endocrine neoplasia type 2. Constitutive RET activation drives oncogenic signaling and promotes uncontrolled cell growth. In normal physiology, RET signaling is essential for neural crest development, kidney morphogenesis, and enteric nervous system formation.
c-RET antibody is suitable for detecting RET proto-oncogene expression in studies of receptor tyrosine kinase signaling and cancer biology. By enabling analysis of RET distribution and abundance, this antibody supports research into oncogenic activation and therapeutic targeting of RET-driven tumors.
Optimal dilution of the c-RET/RET Proto-Oncogene antibody should be determined by the researcher.
A recombinant fragment (within amino acids 702-848) of human RET protein was used as the immunogen for the c-RET/RET Proto-Oncogene antibody.
Aliquot the c-RET/RET Proto-Oncogene antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.